Benchmark Reiterates Buy Rating on Surgery Partners (SGRY) Following Q4 Results
Tweet Send to a Friend
Benchmark analyst Bill Sutherland reiterated a Buy rating and $30.00 price target on Surgery Partners (NASDAQ: SGRY).The analyst commented, "Last ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
